Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence

Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease that up to now has been associated with a poor prognosis. However, the results of the INPULSIS and ASCEND trials and the approval of nintedanib and pirfenidone have marked the beginning of a new era for IPF patients. Questio...

Full description

Bibliographic Details
Main Authors: C. Robalo-Cordeiro, P. Campos, L. Carvalho, A. Borba, S. Clemente, S. Freitas, S. Furtado, J.M. Jesus, C. Leal, A. Marques, N. Melo, C. Souto-Moura, S. Neves, V. Sousa, A. Santos, A. Morais
Format: Article
Language:English
Published: Elsevier 2017-09-01
Series:Revista Portuguesa de Pneumologia (English Edition)
Online Access:http://www.sciencedirect.com/science/article/pii/S2173511517300787

Internet

http://www.sciencedirect.com/science/article/pii/S2173511517300787

Similar Items